Interview
with Neil Love, MD from Breast Cancer Update for Medical Oncologists,
Program 2 2000
Play
Audio Below:
Surgical
oophorectomy has an advantage of being fairly quick and relatively
easily done these days. On the other hand, a large percentage of
people have an aversion to surgery in general, to loosing another
organ, – the feeling "I can change my mind". You
can obviously start with a LHRH agonist and then you can make a
switch at a later time. And it gives us the kind of flexibility
that we just haven’t had in the past. A flexibility even to
start one way, as I said, and then make a decision: "Well,
I’m going to go to surgical therapy later." For example,
you might even go for the five years and at the end of the time,
have an oophorectomy rather than continuing, say, beyond five years.
Combined
endocrine therapy for breast cancer - New life for an old idea? Davidson, N. E. (Reprint available from: Davidson NE Johns Hopkins
Oncol Ctr 1650 Orleans St,Rm 409 Baltimore, MD 21231 USA). Journal
of the National Cancer Institute 92(11):859-860, 2000 Jun 7. No
abstract
